Mounting evidence supports the strong prognostic importance of D-dimers and the impact of
coagulopathy in COVID-19 patients [1, 2, 3]. We would like to emphasize the significance of …

Abstract Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …

CORRESPONDENCE group, 10 (27.8%) in the isolated distal DVT group, and 3 (60%) in
the proximal DVT group died (P= 0.43). In our investigation, the overall rate of developing …

Patients with severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2) pneumonia
with SARS-CoV-2 present with coagulation disorders and marked susceptibility to …

Purpose Little evidence of increased thrombotic risk is available in COVID-19 patients. Our
purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection. Methods All …

Coronavirus disease 2019 (COVID-19) is causing devastating morbidity and mortality
worldwide. Several studies have shown that the severely ill patients have high or very high …

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), 1, 2 that, first identified in China, has spread globally. A …

2. Cook DJ, Crowther MA, Meade MO, Douketis J. VTE in the ICU Workshop Participants.
Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical …

A recently published article by Dr. Tang and colleagues on “Abnormal coagulation
parameters are associated with poor prognosis in patients with novel coronavirus …

Severe COVID-19 illness is associated with intense inflammation, leading to high rates of
thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D …